Viewing Study NCT04949269


Ignite Creation Date: 2025-12-24 @ 10:57 PM
Ignite Modification Date: 2026-01-01 @ 7:12 AM
Study NCT ID: NCT04949269
Status: COMPLETED
Last Update Posted: 2022-03-11
First Post: 2021-06-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Drug Levels of Deucravacitinib From Tablets After Oral Administration in Healthy Participants
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module